This report provides an overview of the World Hepatitis Alliance's impact in 2019, summarising key achievements in raising the importance of hepatitis elimination around the world.
Resources
Drug services professional
Around half of current injecting drug users will have hepatitis C, although this prevalence rate varies across the country. Find here tools, resources and other relevant documents to help drugs service staff raise awareness of hepatitis C amongst service users, and improve testing and access to care.
Showing 71 to 80 of 294 resources
-
World Hepatitis Alliance: 2019 Impact report
Rest of World 08 Apr 2020 Reports & Research PDF
-
Delivering health and care for people who sleep rough
Published in March 2020, this report from The King's Fund on health and care for people who sleep rough focusses on reducing barriers people face to accessing healthcare services and on commissioning appropriate services. The report argues that to improve health outcomes for people sleeping rough we need local authorities to team up with charities and community services; we need both a population health approach and a place-based approach; we need co-production with people with lived experience of sleeping rough; and we need staff working with this group to be properly recruited and supported.UK Reports & Research, Strategy & Planning PDF
-
Routemap to eliminating hepatitis C in London: The Opportunity
On 2nd March 2020, the London Joint Working Group on Substance Use and Hepatitis C (LJWG) launched a 'Routemap to eliminating hepatitis C in London'. This document sets out the opportunities for improving hepatitis C care in London, based around five pillars of improvement: reducing stigma; engaging people who are under-served by traditional health systems; working with GPs to find the undiagnosed; reducing pathway attrition; aligning hepatitis C and HIV public health efforts.UK, Greater London Reports & Research, Strategy & Planning PDF
-
Hepatitis C in London: 2019 report
This report from Public Health England provides an update on the recent epidemiology of hepatitis C in London. Among the report's statistics are an estimate that 63% of people who inject drugs (PWID) in London had ever been infected with hepatitis C in 2018, with 41% of those ever infected having a current hepatitis C infection. It is estimated that 18% of PWID were unaware of their infection (lower than the 35% unaware in England as a whole). In 2017/18, 87% of eligible clients of drug treatment services received a hepatitis C test, a small increase from 86% in 2016/2017.England, Greater London 17 Feb 2020 Reports & Research PDF
-
Good practice case study: Intensive testing at HMP Low Newton
This good practice case study explores how HMP Low Newton micro-eliminated hepatitis C by running an intensive testing weekend in January 2020 which had a phenomenal 99.3% uptake rate.UK Case study PDF
-
Leave No One Behind: Engaging and empowering people in hepatitis C care and treatment through peer support
This report provides an overview of The Hepatitis C Trust's peer-to-peer support work, outlining the various ways the charity's peers supports people at risk of or living with hepatitis C, detailing the results the peer project has achieved and explaining challenges that have been overcome in delivering the programme.UK 30 Jan 2020 Reports & Research, Strategy & Planning PDF
-
The Hepatitis C Trust: Peer-to-peer programme
This video provides an overview of The Hepatitis C Trust's peer-to-peer support work, which involves staff and volunteer peers with lived experience of hepatitis C providing support to those at risk of and living with hepatitis C, raising awareness and supporting access to testing and treatment.UK 30 Jan 2020 Training, Tools & Templates, Strategy & Planning Video
-
One Recovery Bucks BBV Pathway
This best practice resource details the One Recovery Bucks blood borne virus pathway implemented in 2016. The pathway, involving partnership working with the local NHS Trust is much simpler than the previous pathway and is all completed ‘in-house’ at the One Recovery Bucks community drug and alcohol service. The new pathway has resulted in an increase in those who test positive advancing to access treatment from 18% to over 90%.UK 10 Jan 2020 Tools & Templates PDF
-
Good practice case study: One Recovery Bucks BBV Pathway
This good practice case study focuses on the One Recovery Bucks drugs service BBV pathway. Implementation of the pathway has seen the proportion of patients who test positive for hepatitis C going on to access treatment increase from 18% to over 90%.UK 10 Jan 2020 Case study PDF
-
Staying Alive in Scotland: Strategies to Prevent Drug Deaths
This updated toolkit, a partnership between the Scottish Government and Scottish Drugs Forum, updates the original report produced three years ago. The resource notes that DAA treatments for hepatitis C provide an opportunity to prevent drug-related deaths, but that opportunities to test for hepatitis C are being missed.Scotland 20 Dec 2019 Reports & Research PDF